Intrexon Corp

Most Recent

  • uploads///Graph Part
    Company & Industry Overviews

    XBI Moving Averages Are on the Rise

    For the week ended September 11, 2015, the SPDR S&P Biotechnology ETF (XBI) saw a big jump in the number of stocks trading above the 20-day moving average.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    How Does XBI Compare to Its 100-Day Moving Average?

    The SPDR S&P Biotech ETF (XBI) rose marginally by 0.1% on April 20, 2016. Within XBI, Kite Pharma (KITE) closed at $48.98 on the day.

    By Peter Neil
  • uploads///Greenlight
    Consumer

    Why Einhorn’s hedge fund bought a position in Intrexon Corp.

    In this seven-part series, we’ll go through some of the main positions Greenlight Capital LP traded this past quarter. Why buy Intrexon Corp. (XON)?

    By Samantha Nielson
  • uploads///TPX
    Consumer

    Why Einhorn opened a new position in Tempur Sealy International

    Einhorn acquired a small position (0.9%) in Tempur Sealy International Corp in 3Q 2013. Tempur Sealy International posted 111.4% increase in 3Q 2013 net sales.

    By Samantha Nielson
  • uploads///STBZ
    Consumer

    Why Einhorn sold Greenlight’s position in State Bank Financial

    Einhorn exited a 0.5% position in State Bank Financial Corp. He had purchased these shares in 2Q 2011. Net income for 3Q 2013 was $4.3 million.

    By Samantha Nielson
  • uploads///Part  Graph
    Company & Industry Overviews

    XBI Remained Stable as the Markets Rallied on Higher Oil Prices

    On June 8, the biotech and healthcare sectors had a mixed day and remained sluggish. The SPDR S&P Biotech ETF (XBI) gained 0.1% for the day. XBI has fallen by 16.4% on a year-to-date basis.

    By Peter Neil
  • uploads///mine _
    Energy & Utilities

    Crude Oil’s Implied Volatility Suggests It Could Fall below $50

    Yesterday, US crude oil’s implied volatility was 41.3%, 14.4% above its 15-day average.

    By Rabindra Samanta
  • uploads///Part  Graph
    Company & Industry Overviews

    XBI Holdings Finished Strong as Market Bounced Back on April 13

    On April 13, 2016, the SPDR S&P Biotech ETF (XBI) gained 2.4% for the day. XBI outperformed the SPDR S&P 500 ETF (SPY), which gave a return of 1.1%.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    XBI Mid-Cap News: Look Who Took a Beating on March 23

    Among the 18 mid-cap stocks that XBI holds in its portfolio, 17 declined and only one advanced on March 23. Mid-caps represent ~30% of XBI’s portfolio.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    XBI News as of March 16: Mid-Caps Under Pressure

    Given selling pressures, XBI’s 18 mid-cap stocks went down marginally on average, losing 0.4% on March 16. Eight stocks advanced while ten stocks declined.

    By Peter Neil
  • uploads///Graph Part
    Company & Industry Overviews

    ALNY and XON Drag Down Mid-Cap Stocks Last Week

    Alnylam Pharmaceuticals (ALNY) dragged down mid-cap stocks for the week ended September 25. ALNY fell 22.37%, closing at $83.72. It was trading below the 20-day, 50-day, and 100-day moving averages.

    By Peter Neil
  • uploads///Graph Part
    Company & Industry Overviews

    Kite Led Top Ten Stocks by Weight in XBI’s Biotechnology Subgroup

    Kite Pharma (KITE), which has a weight of 1.17% in the SPDR S&P Biotechnology ETF (XBI), rose 21.94% for the week ended September 11.

    By Peter Neil
  • uploads///Graph Part
    Company & Industry Overviews

    IBB Mid-Cap Outperforms XBI Mid-Cap

    IBB mid-cap outperformed XBI mid-cap for the week ended September 4, 2015. The IBB top ten mid-cap stocks returned -3.34%, while the XBI top ten mid-cap stocks returned -4.33% for the same period.

    By Peter Neil
  • uploads///Graph Part
    Company & Industry Overviews

    ICPT and XON Put Pressure on XBI’s Biotechnology Sector

    Intrexon (XON) plummeted by 14.4% after it announced its 2Q15 results. As per the company’s press release, XON’s total revenue was $44.9 million.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    IBB Outperforms XBI: Top 10 Mid-Cap Stocks

    The top ten mid-cap stocks from IBB outperformed the top ten mid-cap stocks from the SPDR S&P Biotechnology ETF (XBI) for the week ending August 7.

    By Peter Neil
  • Energy & Utilities

    Third Point LLC Holdings hedge fund starts new positions in FDX, GOOG, EQT, XON – 13F Flash

    Third Point LLC Holdings, a large U.S. based hedge fund started new positions in Fedex Corp. (FDX), Google Inc. (GOOG), EQT Corp. (EQT), and Intrexon Corp. (XON). Abbreviated financial summaries and metrics for these securities are included below. Detailed analysis and recommendations require a subscription (more information at the bottom of the article). Fedex Corp. […]

    By Samantha Nielson
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.